A.R.T. Advisors’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-11,400
Closed -$218K 1784
2018
Q4
$218K Buy
+11,400
New +$265K 0.01% 1028
2018
Q3
Sell
-21,200
Closed -$778K 1863
2018
Q2
$778K Sell
21,200
-46,900
-69% -$1.52M 0.03% 747
2018
Q1
$2.24M Buy
+68,100
New +$2.13M 0.09% 335
2017
Q3
Sell
-14,900
Closed -$566K 1839
2017
Q2
$566K Buy
+14,900
New +$664K 0.03% 748
2015
Q4
Sell
-73,917
Closed -$2.81M 1841
2015
Q3
$2.81M Sell
73,917
-29,425
-28% -$1.03M 0.1% 267
2015
Q2
$2.96M Sell
103,342
-3,360
-3% -$93.6K 0.1% 309
2015
Q1
$2.99M Buy
+106,702
New +$3M 0.1% 263
2014
Q4
Sell
-160,349
Closed -$3.58M 1770
2014
Q3
$3.58M Buy
160,349
+114,638
+251% +$2.91M 0.17% 172
2014
Q2
$1.33M Buy
45,711
+20,312
+80% +$542K 0.07% 405
2014
Q1
$721K Sell
25,399
-30,076
-54% -$995K 0.04% 618
2013
Q4
$2.14M Buy
+55,475
New +$1.98M 0.11% 261

Other funds holding MDCO

A.R.T. Advisors's MDCO Position: Q1 2019 in Review

A.R.T. Advisors sold out of Medicines Co (MDCO) in Q1 2019, closing a stake of 11,400 shares — an estimated $218K sold.

A.R.T. Advisors first reported a position in MDCO in Q4 2013 and held it in 11 quarters. The position peaked at $3.58M in Q3 2014. 203 funds tracked by Wall St. Rank hold MDCO as of Q1 2019.

  • A.R.T. Advisors reported no remaining Medicines Co position as of Q1 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 11,400 Medicines Co shares in Q1 2019, an estimated $218K.
  • A.R.T. Advisors first reported a position in Medicines Co in Q4 2013 and held it in 11 quarters.
  • A.R.T. Advisors's Medicines Co position peaked at $3.58M in Q3 2014.
  • 203 funds tracked by Wall St. Rank held Medicines Co as of Q1 2019.

Based on A.R.T. Advisors's 13F filing for Q1 2019, filed 15 May 2019.